204 related articles for article (PubMed ID: 21480242)
1. Translational/personalized medicine, pharmaco/surgico/radiogenomics, lymphatic spread of cancer, and medical ignoromes.
Witte MH
J Surg Oncol; 2011 May; 103(6):501-7. PubMed ID: 21480242
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine: does the molecular suit fit?
Liu ET; Johnston PG
Oncologist; 2013 Jun; 18(6):653-4. PubMed ID: 23814161
[No Abstract] [Full Text] [Related]
3. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
4. Genetics and genomics: the scientific drivers of personalized medicine.
Kurnat-Thoma EL
Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
[TBL] [Abstract][Full Text] [Related]
5. Response to "personalized medicine, genomics, and pharmacogenomics".
Mayer DK
Clin J Oncol Nurs; 2014 Dec; 18(6):618. PubMed ID: 25427694
[No Abstract] [Full Text] [Related]
6. Cancer genomics: from discovery science to personalized medicine.
Chin L; Andersen JN; Futreal PA
Nat Med; 2011 Mar; 17(3):297-303. PubMed ID: 21383744
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
Blix A
Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
[TBL] [Abstract][Full Text] [Related]
8. Cancer genomics guide clinical practice in personalized medicine.
Lehmann-Che J; Poirot B; Boyer JC; Evrard A
Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
[TBL] [Abstract][Full Text] [Related]
9. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
Tavakolpour S; Darvishi M; Ghasemiadl M
Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
[TBL] [Abstract][Full Text] [Related]
11. The Festival of Genetics and Personalized Medicine.
Therianou M; Gerou A; Mitropoulos K; Patrinos GP
Pharmacogenomics; 2022 Jun; 23(9):509-511. PubMed ID: 35670264
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Pharmacogenomics in Personalized Medicine.
Singh DB
Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703
[TBL] [Abstract][Full Text] [Related]
13. Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable.
David SP; Johnson SG; Berger AC; Feero WG; Terry SF; Green LA; Phillips RL; Ginsburg GS
Ann Fam Med; 2015; 13(4):373-80. PubMed ID: 26195686
[TBL] [Abstract][Full Text] [Related]
14. The Interface of Therapeutics and Genomics in Cardiovascular Medicine.
Magavern EF; Kaski JC; Turner RM; Janmohamed A; Borry P; Pirmohamed M
Cardiovasc Drugs Ther; 2021 Jun; 35(3):663-676. PubMed ID: 33528719
[TBL] [Abstract][Full Text] [Related]
15. Surveying Recent Themes in Translational Bioinformatics: Big Data in EHRs, Omics for Drugs, and Personal Genomics.
Denny JC
Yearb Med Inform; 2014 Aug; 9(1):199-205. PubMed ID: 25123743
[TBL] [Abstract][Full Text] [Related]
16. Translational bioinformatics and systems biology approaches for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
[TBL] [Abstract][Full Text] [Related]
17. A Review of Recent Advances in Translational Bioinformatics: Bridges from Biology to Medicine.
Vamathevan J; Birney E
Yearb Med Inform; 2017 Aug; 26(1):178-187. PubMed ID: 29063562
[No Abstract] [Full Text] [Related]
18. Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine.
Mitropoulos K; Innocenti F; van Schaik RH; Lezhava A; Tzimas G; Kollia P; Macek M; Fortina P; Patrinos GP
Pharmacogenomics; 2012 Mar; 13(4):387-92. PubMed ID: 22379996
[TBL] [Abstract][Full Text] [Related]
19. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
[TBL] [Abstract][Full Text] [Related]
20. Genomics, personalized medicine, and supportive cancer care.
Sonis ST
Am Soc Clin Oncol Educ Book; 2015; ():9-16. PubMed ID: 25993135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
